Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3350
Abstract: The survival benefits of perioperative chemoradiotherapy (PCRT) and perioperative chemotherapy (PCT) for resectable gastric cancer (GC) patients remain unclear. This study aimed to compare the effects of PCRT and PCT in patients with resectable GC… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "International Journal of Hyperthermia"
DOI: 10.1080/02656736.2022.2122595
Abstract: Abstract Aims To evaluate the long-term survival benefits of high intensity focused ultrasound (HIFU) ablation in patients with hepatocellular carcinoma (HCC) combined with portal vein tumor thrombus (PVTT). Methods The data of patients with HCC-PVTT… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Pancreas"
DOI: 10.1097/mpa.0000000000001000
Abstract: 4 cases of pancreatitis (1.98%). In these cases, the admission length of stay was 4, 7, 14, and 15 days. This subgroup of patients with pancreatitis had a significantly longer inpatient stay than that noted… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Journal of intensive care medicine"
DOI: 10.1177/08850666231170775
Abstract: OBJECTIVES To summarize the role of therapeutic plasma exchange (TPE) in critically ill adults and children with severe sepsis. DATA COLLECTION A systematic search was performed using the following databases: Medline, EMBASE, CINAHL, and Cochrane… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "BMC Cancer"
DOI: 10.1186/s12885-017-3889-x
Abstract: BackgroundSorafenib is a multiple receptor tyrosine kinase inhibitor known to prolong overall survival in patients with advanced hepatocellular carcinoma (HCC). Predicting this drug’s survival benefits is challenging because clinical responses are rarely measurable during treatment.… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.719253
Abstract: Background Metastatic pancreatic cancer (mPC) is a highly lethal malignancy with poorer survival. However, chemotherapy alone was unable to maintain long‐term survival. This study aimed to evaluate the individualized survival benefits of pancreatectomy plus chemotherapy… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Cancers"
DOI: 10.3390/cancers11020133
Abstract: Oligometastatic disease is defined as “a condition with a few metastases arising from tumors that have not acquired a potential for widespread metastases.” Its behavior suggests a transitional malignant state somewhere between localized and metastatic… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of gynecologic oncology"
DOI: 10.3802/jgo.2022.33.e40
Abstract: OBJECTIVE The survival benefits of retroperitoneal lymphadenectomy (RLNA) for epithelial ovarian cancer (EOC) remain controversial because clinical behaviors differ among subtypes. The purpose of the present study was to clarify whether RLNA increases the survival… read more here.